We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Abdominal Exploration Without Incisions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00427752
Recruitment Status : Completed
First Posted : January 29, 2007
Last Update Posted : May 7, 2012
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Description
Brief Summary:
This study is being conducted to determine whether an endoscope, (a small, flexible tube with a camera mounted on the end) passed down through the throat, through the stomach, and into the abdomen can safely and accurately examine the organs and tissue of the abdomen and take biopsies if needed. We wish to determine if this endoscopic diagnostic route is as efficient as the laparoscopic diagnostic route, which is currently the standard of care.

Condition or disease Intervention/treatment Phase
Pancreatic Cancer Procedure: Transgastric endoscopic peritoneoscopy. Early Phase 1

Detailed Description:

We propose to investigate the efficacy of transgastric endoscopic peritoneoscopy with endoscopic biopsy in patients undergoing diagnostic laparoscopy and who will require a concurrent gastrotomy for placement of a PEG, gastrojejunostomy or gastric resection.

We hypothesize that diagnostic endoscopic peritoneoscopy can be done safely with adequate visualization of the abdominal cavity to direct clinical treatment.


Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: Single (Investigator)
Primary Purpose: Diagnostic
Official Title: Diagnostic Transluminal Endoscopic Peritoneoscopy
Study Start Date : October 2006
Primary Completion Date : January 2012
Study Completion Date : January 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Whipple
Patients with pancreatic cancer who will proceed to a Whipple procedure.
Procedure: Transgastric endoscopic peritoneoscopy.
Exploration of the abdominal area


Outcome Measures

Primary Outcome Measures :
  1. 1) That transgastric endoscopic peritoneoscopy is feasible. [ Time Frame: 4/12 ]

Secondary Outcome Measures :
  1. That bacterial abdominal contamination is not clinically significant. [ Time Frame: 04/11 ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pancreatic Cancer undergoing staging laparoscopy
  • Staging or diagnostic laparoscopy in anyone needing enteral access

Exclusion Criteria:

  • Lack of consent
  • Intra-abdominal adhesions precluding diagnostic laparoscopy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00427752


Locations
United States, Ohio
The Ohio State University Center for Minimally Invasive Surgery
Columbus, Ohio, United States, 43210
Sponsors and Collaborators
Jeffrey Hazey
Stryker Nordic
Ethicon Endo-Surgery
Investigators
Principal Investigator: Jeffrey W Hazey, MD Ohio State University
Principal Investigator: William S Melvin, MD Ohio State University
More Information

Publications:
Responsible Party: Jeffrey Hazey, Associate Professor, The Ohio State University
ClinicalTrials.gov Identifier: NCT00427752     History of Changes
Other Study ID Numbers: 2006H0120
First Posted: January 29, 2007    Key Record Dates
Last Update Posted: May 7, 2012
Last Verified: May 2012

Keywords provided by Jeffrey Hazey, The Ohio State University:
Transgastric
Endoluminal
Peritoneoscopy
Diagnostic
Feasibility

Additional relevant MeSH terms:
Pancreatic Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases